Bio Interest Coverage from 2010 to 2026

TECH Stock  USD 63.79  0.00  0.00%   
Bio Techne's Interest Coverage is decreasing with slightly volatile movements from year to year. Interest Coverage is predicted to flatten to 13.13. For the period between 2010 and 2026, Bio Techne, Interest Coverage quarterly trend regression had mean deviation of  37.39 and range of 109. View All Fundamentals
 
Interest Coverage  
First Reported
2010-12-31
Previous Quarter
13.82
Current Value
13.13
Quarterly Volatility
40.98800611
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 132.7 M, Total Revenue of 1.5 B or Gross Profit of 954.3 M, as well as many indicators such as Price To Sales Ratio of 6.86, Dividend Yield of 0.0106 or PTB Ratio of 6.72. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
  
Build AI portfolio with Bio Stock
Check out the analysis of Bio Techne Correlation against competitors.
The Interest Coverage trend for Bio Techne Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Bio Techne is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Bio Techne's Interest Coverage Growth Pattern

Below is the plot of the Interest Coverage of Bio Techne Corp over the last few years. It is Bio Techne's Interest Coverage historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bio Techne's overall financial position and show how it may be relating to other accounts over time.
Interest Coverage10 Years Trend
Slightly volatile
   Interest Coverage   
       Timeline  

Bio Interest Coverage Regression Statistics

Arithmetic Mean43.97
Geometric Mean27.48
Coefficient Of Variation93.21
Mean Deviation37.39
Median17.01
Standard Deviation40.99
Sample Variance1,680
Range109
R-Value(0.83)
Mean Square Error556.46
R-Squared0.69
Significance0.000037
Slope(6.74)
Total Sum of Squares26,880

Bio Interest Coverage History

2025 13.82
2024 12.02
2023 13.13
2022 26.66
2021 26.23
2020 17.01
2019 8.2

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's Interest Coverage, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Interest Coverage 13.82  13.13 

Currently Active Assets on Macroaxis

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Check out the analysis of Bio Techne Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is there potential for Life Sciences Tools & Services market expansion? Will Bio introduce new products? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.143
Dividend Share
0.32
Earnings Share
0.49
Revenue Per Share
7.762
Quarterly Revenue Growth
(0.01)
Understanding Bio Techne Corp requires distinguishing between market price and book value, where the latter reflects Bio's accounting equity. The concept of intrinsic value—what Bio Techne's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Bio Techne's price substantially above or below its fundamental value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Bio Techne's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.